CIDRAP newsletters options
A randomized phase 3 trial found that the combination of daptomycin and fosfomycin provided higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis, but the difference did not reach statistical significance, Spanish researchers reported yesterday in Clinical Infectious Diseases.
With the dramatic nationwide rise in COVID-19 cases, widespread concerns about thin supplies of protective equipment remain.
One study finds that staff working at more than one nursing home had quadruple the risk of infection.
A dramatically scaled-back version of the hajj pilgrimage began in Saudi Arabia yesterday.
Younger people appear to be spreading the virus to older family members, according to a new report.
One more Ebola case has been confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, raising the total to 68 cases, the World Health Organization (WHO) African regional office said today on Twitter.
The patient is apparently from Mbandaka, the provincial capital, which is a concern, given its travel connections to Kinshasa and neighboring countries. The number of deaths held steady at 31.
An observational study of 10,021 COVID-19 patients admitted to 920 German hospitals has found that patients requiring mechanical ventilation were at highest risk for death—especially those 80 years and older and those needing dialysis.
Arizona has seen a 13% decrease in its 7-day average, Florida an 8% drop, and Texas a 19% decline.
Vietnam, Greece, Germany, and other nations that had low levels scramble to address flare-ups.
Some CDC data assessment may perpetuate racial disparities, one study finds.
The consumption of "Watch" antibiotics, which are broad-spectrum, rose by 91%.
More than 2 million American workers called in sick in a single week in mid-April, causing the highest absence rate on record and leading to suspicions that COVID-19 cases were substantially undercounted, according to a research letter published yesterday in JAMA Internal Medicine.
WHO officials stressed that even intense transmission countries can turn their outbreaks around with leadership, consistent messaging, and key measures.
The vaccine trial is starting against a backdrop of a vigorous US outbreak, in which three states outside the main hot spots reported record highs: Oklahoma, Missouri, and North Dakota.
Two German studies published today in JAMA Cardiology show abnormal heart imaging findings in recently recovered COVID-19 patients.
Two more Ebola infections and two more deaths from the virus have been reported from the Democratic Republic of the Congo (DRC) Equateur province outbreak, the World Health Organization (WHO) African regional office said on Twitter today.
In a comparative analysis published late last week in Clinical Infectious Diseases, the antiviral drug remdesivir was linked to significantly greater recovery and a 62% lower death rate by day 14 versus standard treatment in hospitalized adults with severe COVID-19.
"We need to reopen the schools with the understanding the virus is still here," CDC Director Robert Redfield says.
In India, surging COVID-19 has led to remdesivir shortages, and the outbreak is expanding in Brazil.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Scientists in Luxembourg this week announced the creation of a new biobank that will collect and analyze strains of bacteria from Europe that are resistant to last-resort antibiotics.
